What AMI Technologies does

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceutical products, and surgical technologies, operating since 1986 as the local representative for leading international manufacturers from Europe and the United States. Headquartered in Hod Hasharon, the company sells to Israeli hospitals (enterprise), medical and aesthetic clinics (mid-market), and individual treatment rooms (SMB), covering clinical specialties that include dermatology and aesthetics, plastic surgery, neurosurgery, orthopedics, urology, cardiology, imaging, ENT, vascular, and women's health. The portfolio spans 24-plus products including laser platforms (Hollywood Spectra, eCO2 3D, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical platforms (vNOTES, Stryker neurosurgery and endoscopy, BK Medical intraoperative ultrasound), and diagnostic devices (Clarius wireless ultrasound, T-Stat tissue oximeter, FemaSeed, FemVue).

The business model is B2B distribution on a quote-based pricing structure, with revenue generated from hardware sales of manufacturer-supplied equipment and consumables to Israeli healthcare providers. The company holds ISO 9001, ISO 27001, and ISO 27799 certifications updated to the 2022 version. Go-to-market is multi-channel: direct sales force coverage of hospitals and clinics, manufacturer-aligned training workshops, on-demand video content for physicians, and a Hebrew/English website (ami.co.il) supported by LinkedIn and Facebook presence. Recent strategic activity (2023-2026) has focused on expanding the regenerative medicine and fertility verticals through new principal partnerships (including Femasys Inc. in April 2026) and broadened product launches. The company is led by CEO Teli Schecter, operates as a privately held Israeli limited company, and has no disclosed ownership changes, institutional investors, or M&A activity.

Ownership structure is private with no publicly disclosed shareholders, venture backing, or private equity involvement. The company is a channel partner for international manufacturers rather than a developer of proprietary technology, and all devices distributed are FDA, CE, and AMAR approved by their respective manufacturers. Recent portfolio momentum includes entry into fertility/women's health (Femasys), regenerative medicine (Biosome MDX exosomes, Mastelli PLINEST polynucleotides), and seven-plus new product launches in 2026 alone.

Name

AMI Technologies

Legal name

AMI Medical Technologies Ltd. (אמי טכנולוגיות רפואיות בע״מ)

Website

https://ami.co.il

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

51–100 employees

Short description

AMI Technologies is an Israeli-exclusive distributor of advanced medical devices, biopharmaceuticals, and surgical technologies for leading global manufacturers, serving hospitals, clinics, and treatment rooms across multiple specialties since 1986.

Ownership category

akta.pro rank

Headquarters

HQ city

Hod Hasharon

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Device Distribution: Distribution of medical devices and technologies to healthcare providers including hospitals, clinics, and treatment rooms. Revenue generated through sales of equipment from international manufacturer partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

AMI Technologies is the exclusive Israeli distributor for leading international medical technology manufacturers, marketing and selling advanced medical devices, biopharmaceutical products and surgical systems to hospitals, clinics and private treatment rooms. The company supplies a multi-specialty portfolio spanning dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology and imaging, and provides accompanying training, implementation and after-sales support.

Product overview

AMI Technologies is a leading Israeli medical technology distributor offering a comprehensive portfolio of medical devices, biopharmaceutical products, and surgical technologies across multiple specialties including dermatology/aesthetics, regenerative medicine, plastic surgery, neurosurgery, orthopedics, urology, cardiology, and imaging. The portfolio includes laser platforms (Hollywood Spectra, eCO2, MOSAIC 3D, Ultra, DERMA V, Xeo Plus, AviClear), energy-based devices (Tixel, Ultraformer MPT, XERF), injectable biopharmaceuticals (Sculptra, Restylane, Cellbooster, AnteAGE MD, Biosome MDX, Mastelli PLINEST), surgical systems (vNOTES/Gel Point, Stryker instruments, BK Medical ultrasound), and diagnostic/monitoring devices (Clarius, T-Stat, FemaSeed, FemVue). The company operates as an exclusive distributor for major international manufacturers including Stryker, Galderma, Lutronic, Cutera, and others, providing both products and comprehensive service support to healthcare providers in Israel.

Differentiator

Problem solved

Functional benefit

Products and services

• Tixel Thermal fractional system for skin rejuvenation, anti-aging treatments, and aesthetic indications including wrinkles, acne scars, and skin texture improvement, sold to dermatologists and aesthetic clinics.
• Ultraformer MPT Advanced HIFU (High-Intensity Focused Ultrasound) device for non-invasive lifting, skin tightening, and body contouring treatments, marketed to aesthetic clinics and plastic surgery practices.
• Cellbooster Stabilized booster complex for injection based on non-cross-linked hyaluronic acid with active ingredients using CHAC technology for delayed release, marketed to dermatologists and aesthetic physicians.
• AnteAGE MD Product line based on cytokines and growth factors for various dermatological and aesthetic indications, combined with medical devices, marketed to aesthetic physicians.
• Biosome MDX Synthetic exosome product for enhancing tissue regenerative capacity, containing concentrated proteins and growth factors for dermatological indications, marketed to aesthetic physicians.
• Sculptra Collagen biostimulator containing poly-L-lactic acid microparticles that stimulates natural collagen production for skin quality improvement, marketed to aesthetic and dermatology practices.
• Restylane Hyaluronic acid dermal fillers for facial contouring, sculpting and enhancement using NASHA and OBT technologies, marketed to aesthetic clinics and plastic surgeons.
• Restylane Skinboosters Stabilized hyaluronic acid for skin quality improvement, providing deep hydration and improving skin texture and radiance, marketed to aesthetic physicians.
• Clarius Wireless handheld ultrasound scanner with 20MHz frequency for high-quality imaging in aesthetic and surgical procedures, marketed to plastic surgeons and aesthetic clinics.
• T-Stat VLS Tissue Oximeter using White Light Technology for continuous, non-invasive tissue monitoring, marketed to surgical and aesthetic practices.
• Hollywood Spectra Q-Switched Nd:YAG laser platform with Hollywood Laser Peel for skin rejuvenation, tattoo removal and pigment treatments, marketed to aesthetic clinics.
• SkinPen Elite Medical-grade microneedling device for skin rejuvenation, scar treatment, and collagen induction therapy, marketed to dermatologists and aesthetic practices.
• LipoDefine Minimal invasive laser technology using 1470nm or 980nm wavelengths for fat dissolution and skin tightening, marketed to plastic surgeons and aesthetic clinics.
• XERF Dual-frequency RF platform combining 6.78MHz and 2MHz for non-invasive skin lifting, tightening and tissue remodeling, marketed to aesthetic practices.
• AviClear Laser platform using 1726nm wavelength for long-term acne treatment by targeting sebaceous glands, marketed to dermatologists.
• MOSAIC 3D Non-ablative fractional laser platform using 3D Controlled Chaos Technology at 1550nm for wrinkle, scar, and skin texture treatments, marketed to aesthetic clinics.
• Ultra Thulium 1927nm fractional laser with Magnetic Roller Tracking for skin rejuvenation and pigment treatment, marketed to aesthetic practices.
• DERMA V

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Femasys Inc.coreChannel Partner/ Reseller/ Distributor · 16 April 2026Femasys Inc. partnered with AMI Technologies to commercialize its FemaSeed artificial insemination device and FemVue diagnostic tool in Israel. AMI Technologies handles distribution and commercialization through its existing healthcare provider network. FemaSeed has regulatory approvals in multiple markets including US, Europe, and UK, and achieved pregnancy rates more than double those of standard intrauterine insemination in clinical trials.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Medline Industries: Largest privately held medical supply manufacturer and distributor in the US, offering medical-surgical products to hospitals and healthcare facilities. Comparable as a private specialty medical distributor with manufacturer partnerships.
• Cardinal Health: One of the largest healthcare distribution companies globally, distributing medical and surgical products to hospitals, pharmacies, and physician offices. Operates at much larger scale but exemplifies the broad incumbent medical distribution model.
• Henry Schein: Global Fortune 500 medical and dental products distributor serving healthcare providers worldwide. Comparable as the largest medical device distribution platform, though far larger and broader than AMI's Israel-exclusive specialty focus.
• McKesson Medical-Surgical: Leading medical-surgical supply distributor serving more than 250,000 US healthcare customers. Comparable medical device and supply distribution model with extensive manufacturer relationships.
• Patterson Companies: US-focused medical and dental distributor with similar value-added services model (sales, equipment, technology solutions) to healthcare providers. Comparable as a specialty medical distributor with manufacturer representation relationships, though focused on US/Canada.
• B. Braun Medical: German medical device and pharmaceutical company with direct distribution to hospitals worldwide. Comparable as a manufacturer-distributor model serving Israeli healthcare (B. Braun has Israel operations) with multi-specialty medical device portfolios.
• Owens & Minor: Major medical/surgical product distribution and healthcare supply chain company. Comparable business model of distributing medical products to hospitals and healthcare providers with value-added services.

Regional players

• Lapidot Group: Israeli medical device and pharmaceutical distributor representing international manufacturers in Israel. Comparable as a regional specialty medical distributor with similar exclusive distribution agreements and Israeli market focus.
• Medison Group: Israeli specialty pharmaceutical and medical device distribution company with exclusive representation of international manufacturers. Comparable as a regional player with exclusive distribution model and similar Israel-market focus.

Others

• Stryker (Israel): One of AMI's largest manufacturer partners; global medical device giant with direct Israel operations. Relevant as a key supplier whose relationship dynamics are central to AMI's business risk profile, though not a true peer (manufacturer, not distributor).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/amitechnologiesil
• LinkedInlinkedin.com/company/amitechnologies

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMI Technologies